Home » Topics » Regulatory

Regulatory
RSS

New E.U. approvals sought for Pennsaid

Sep. 16, 2002

Milnacipran phase II trial in FMS completes enrollment ahead of schedule

Sep. 13, 2002

J&J to file for two new indications for Topamax

Sep. 12, 2002

Pediatric indication approved for Zenapax

Sep. 4, 2002

Lexapro approved for treatment and maintenance treatment of major depressive disorder

Sep. 2, 2002

E.U. approval for Visudyne

Sep. 2, 2002

Neulasta approved in E.U.

Aug. 30, 2002

E.U. approval for Aranesp

Aug. 29, 2002

Ortho Tri-Cyclen Lo receives FDA approval

Aug. 26, 2002

FDA approves pediatric labeling of Prevacid

Aug. 9, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...